Next Article in Journal
Evaluation of Patient-Reported Outcome Differences by Radiotherapy Techniques for Bone Metastases in A Population-Based Healthcare System
Next Article in Special Issue
Access Denied? The Unintended Consequences of Pending Drug Pricing Rules
Previous Article in Journal
Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s RWE Data Working Group
Previous Article in Special Issue
Determinants of the Cancer Drug Funding Process in Canada
 
 
Viewpoint

Article Versions Notes

Curr. Oncol. 2022, 29(3), 2064-2072; https://doi.org/10.3390/curroncol29030166
Action Date Notes Link
article pdf uploaded. 17 March 2022 17:33 CET Version of Record https://www.mdpi.com/1718-7729/29/3/166/pdf-vor
article xml file uploaded 18 March 2022 03:56 CET Original file -
article xml uploaded. 18 March 2022 03:56 CET Update https://www.mdpi.com/1718-7729/29/3/166/xml
article pdf uploaded. 18 March 2022 03:56 CET Updated version of record https://www.mdpi.com/1718-7729/29/3/166/pdf
article html file updated 18 March 2022 03:57 CET Original file -
article html file updated 1 August 2022 06:17 CEST Update https://www.mdpi.com/1718-7729/29/3/166/html
Back to TopTop